-
BIA report: 2018 was a record year for UK biotech fundraising
pharmaceutical-technology
January 25, 2019
A report by the UK Bio Industry Association (BIA) and Informa Pharmaceutical Intelligence recorded that the UK biotech sector raised £2.2bn from investors in 2018.....
-
NHS plans for UK medicines supply in no-deal Brexit
pharmaceutical-technology
January 22, 2019
The UK National Health Service (NHS) has announced contingency plans to ensure there is no disruption to medicines supply for patients in the event of a no-deal Brexit....
-
UK and Japan partner on treatments for degenerative diseases
pharmaceutical-technology
January 15, 2019
Medical researchers in the UK and Japan are set to work together on advancing research aimed at developing treatments for chronic degenerative and incurable diseases, including diabetes and heart disease.....
-
NHS overcrowding leads to ambulances being turned away
pharmafile
December 18, 2018
NHS England’s first weekly report of the winter has revealed that 95% of hospital beds are occupied, while anything above 85% is unsafe.
-
UK opens doors to cannabis-based therapies via NHS
pharmaphorum
December 17, 2018
Medical cannabis is available to certain patients across the UK for the first time from today.The groundbreaking decision was made so that .....
-
AstraZeneca partners up with CRUK for new UK cancer drug discovery facility
pharmafile
December 11, 2018
AstraZeneca is to team up with Cancer Research UK to build a new centre of excellence for accelerating the discovery and development of new cancer drugs, leveraging genetic screening, cancer modelling.
-
UK warns that no-deal Brexit could lead to "significantly reduced access" at borders for up to six months
firstwordpharma
December 10, 2018
The UK government on Friday warned that the absence of an exit agreement between the UK and EU could result in as much as six months of "significantly reduced access" at UK ports. Health Minister Matt Hancock noted that as a consequence, other measures wi
-
Mallinckrodt to split business
pharmatimes
December 10, 2018
UK-based specialty pharma group Mallinckrodt has unveiled plans to spin-off its specialty generics and active pharmaceutical ingredients business into a new company.
-
Mereo BioPharma and OncoMed propose merger
pharmatimes
December 10, 2018
The transaction will create a combined business with a diversified combined portfolio of seven assets, which will result in an increased number of potential near-term catalysts with a core focus remaining
-
UCB to invest £1 billion into UK R&D
pharmafile
December 10, 2018
The Brussels-based multinational UCB will invest £1 billion into UK research and development, according to the government’s Life Sciences Sector Deal, which details public and private sector